Clover Health Investments, Corp. (CLOV)

Despite disappointing YTD earnings due to higher than expected medical costs, Clover's expected GAAP profitability in 2026 marks a critical inflection point. Clover's higher returning member mix and t...

WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...

Clover Health Investments (NASDAQ: CLOV - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both medical companies, but which is the better investment? We will contrast the ...

Clover Health Investments, Corp. ( CLOV ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Kuipers - Chief Financial Officer Presentation Unknown Analyst...

Clover Health Investments (CLOV) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the seve...

Clover Health's Q3 sales soar 50%, but higher Insurance costs and a raised BER outlook weigh on investor sentiment....

Teacher Retirement System of Texas boosted its stake in shares of Clover Health Investments, Corp. (NASDAQ: CLOV) by 4.5% during the undefined quarter, according to its most recent 13F filing with the...

Clover Health Investments, Corp. ( CLOV ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Schmidt - Investor Relations Analyst Andrew Toy - Co-Founder, CEO & Director Pete...